» Articles » PMID: 27350368

Comprehensive Investigation of Aberrant MicroRNA Profiling in Bladder Cancer Tissues

Overview
Journal Tumour Biol
Publisher Sage Publications
Specialty Oncology
Date 2016 Jun 29
PMID 27350368
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

There has been accumulative evidence that microRNAs (miRNAs) play essential roles in the tumorigenesis and progression of bladder cancer. However, individual studies and small sample size caused discrepant outcomes. Thus, the current study focused on a comprehensive profiling of all differentially expressed miRNAs in a total of 519 bladder cancer tissue samples, based on miRNA microarray data. Altogether, 11 prioritized miRNAs stated by 21 published microarray datasets, including five down-regulated (miR-133a-3p, miR-1-3p, miR-99a-5p, miR-490-5p, and miR-133b) and six up-regulated candidate miRNAs (miR-182-5p, miR-935, miR-518e-3p, miR-573, miR-100-3p, and miR-3171) were analyzed with vote-counting strategy and a Robust Rank Aggregation method. Subsequently, miRNA in silico target prediction and potential pathway enrichment analysis were performed to investigate the prospective molecular mechanism of miRNAs in the tumorigenesis of bladder cancer. We found that most of the relative pathways of the aberrantly expressed miRNAs found in the current study were closely correlated with different biological processes, cellular components, molecular functions, cancer pathogeneses, and some cell signalings, such as Wnt signaling, insulin/IGF, PI3 kinase, and FGF signaling pathways. Hence, a comprehensive overview on the miRNA expression pattern in bladder cancer tissues was gained by the current study. These miRNAs might be involved in the tumorigenesis and deterioration of bladder cancer.

Citing Articles

Prognostic Implication of a Cuproptosis-Related miRNA Signature in Hepatocellular Carcinoma.

Jin Z, Wang M, Meng Y, Chen D, Xu Y, Jiang X J Healthc Eng. 2022; 2022:4694323.

PMID: 36147869 PMC: 9489400. DOI: 10.1155/2022/4694323.


Long non-coding RNA OTUD6B-AS1 overexpression inhibits the proliferation, invasion and migration of colorectal cancer cells via downregulation of microRNA-3171.

Wang W, Cheng X, Zhu J Oncol Lett. 2021; 21(3):193.

PMID: 33574932 PMC: 7816294. DOI: 10.3892/ol.2021.12454.


Deciphering of Key Pharmacological Pathways of Poria Cocos Intervention in Breast Cancer Based on Integrated Pharmacological Method.

Ma X, Wu J, Liu C, Li J, Dong S, Zhang X Evid Based Complement Alternat Med. 2020; 2020:4931531.

PMID: 33149754 PMC: 7603580. DOI: 10.1155/2020/4931531.


Expression of miR-182 and Foxo3a in patients with bladder cancer correlate with prognosis.

Chen H, Xu L, Wang L Int J Clin Exp Pathol. 2020; 12(11):4193-4203.

PMID: 31933819 PMC: 6949789.


MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip.

Gao L, Yan S, Yang J, Kong J, Shi K, Ma F BMC Med Genomics. 2020; 13(1):3.

PMID: 31906958 PMC: 6945423. DOI: 10.1186/s12920-019-0648-7.


References
1.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

2.
Kriebel S, Schmidt D, Holdenrieder S, Goltz D, Kristiansen G, Moritz R . Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer. PLoS One. 2015; 10(1):e0117284. PMC: 4309610. DOI: 10.1371/journal.pone.0117284. View

3.
Dyrskjot L, Ostenfeld M, Bramsen J, Silahtaroglu A, Lamy P, Ramanathan R . Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res. 2009; 69(11):4851-60. DOI: 10.1158/0008-5472.CAN-08-4043. View

4.
Pan F, Mao H, Deng L, Li G, Geng P . Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis. Int J Clin Exp Pathol. 2014; 7(9):5622-33. PMC: 4203174. View

5.
Chen X, Wang K, Xu Z, Li S, Liu Q, Fu D . MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1. Cancer Cell Int. 2014; 14:70. PMC: 4238049. DOI: 10.1186/s12935-014-0070-3. View